DexCom PE Ratio 2010-2024 | DXCM

Current and historical p/e ratio for DexCom (DXCM) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. DexCom PE ratio as of November 01, 2024 is 41.38.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

DexCom PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-11-01 70.35 42.13
2024-09-30 67.04 $1.67 40.14
2024-06-30 113.38 $1.62 69.99
2024-03-31 138.70 $1.55 89.48
2023-12-31 124.09 $1.31 94.73
2023-09-30 93.30 $0.91 102.53
2023-06-30 128.51 $0.86 149.43
2023-03-31 116.18 $0.70 165.97
2022-12-31 113.24 $0.81 139.37
2022-09-30 80.54 $0.54 148.46
2022-06-30 74.53 $0.48 155.27
2022-03-31 127.90 $0.52 247.15
2021-12-31 134.24 $0.39 346.42
2021-09-30 136.72 $1.31 104.56
2021-06-30 106.75 $1.31 81.33
2021-03-31 89.85 $1.28 70.47
2020-12-31 92.43 $1.23 75.45
2020-09-30 103.06 $0.61 170.34
2020-06-30 101.35 $0.55 185.11
2020-03-31 67.32 $0.40 169.35
2019-12-31 54.69 $0.27 202.54
2019-09-30 37.31 $-0.49 0.00
2019-06-30 37.46 $-0.48 0.00
2019-03-31 29.78 $-0.37 0.00
2018-12-31 29.95 $-0.36 0.00
2018-09-30 35.76 $0.12 304.34
2018-06-30 23.75 $-0.02 0.00
2018-03-31 18.54 $-0.10 0.00
2017-12-31 14.35 $-0.15 0.00
2017-09-30 12.23 $-0.14 0.00
2017-06-30 18.29 $-0.19 0.00
2017-03-31 21.18 $-0.26 0.00
2016-12-31 14.93 $-0.20 0.00
2016-09-30 21.92 $-0.17 0.00
2016-06-30 19.83 $-0.25 0.00
2016-03-31 16.98 $-0.20 0.00
2015-12-31 20.48 $-0.18 0.00
2015-09-30 21.47 $-0.18 0.00
2015-06-30 20.00 $-0.07 0.00
2015-03-31 15.59 $-0.08 0.00
2014-12-31 13.76 $-0.08 0.00
2014-09-30 10.00 $-0.10 0.00
2014-06-30 9.92 $-0.10 0.00
2014-03-31 10.34 $-0.11 0.00
2013-12-31 8.85 $-0.11 0.00
2013-09-30 7.06 $-0.13 0.00
2013-06-30 5.61 $-0.17 0.00
2013-03-31 4.18 $-0.19 0.00
2012-12-31 3.40 $-0.20 0.00
2012-09-30 3.76 $-0.21 0.00
2012-06-30 3.24 $-0.20 0.00
2012-03-31 2.61 $-0.18 0.00
2011-12-31 2.33 $-0.17 0.00
2011-09-30 3.00 $-0.17 0.00
2011-06-30 3.62 $-0.17 0.00
2011-03-31 3.88 $-0.20 0.00
2010-12-31 3.41 $-0.25 0.00
2010-09-30 3.31 $-0.27 0.00
2010-06-30 2.89 $-0.29 0.00
2010-03-31 2.44 $-0.32 0.00
2009-12-31 2.02 $-0.30 0.00
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $27.478B $3.622B
DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $213.123B 26.03
Intuitive Surgical (ISRG) United States $180.348B 94.29
Alcon (ALC) Switzerland $45.275B 31.87
Edwards Lifesciences (EW) United States $40.686B 25.30
IQVIA Holdings (IQV) United States $37.963B 20.92
IDEXX Laboratories (IDXX) United States $34.345B 40.24
Waters (WAT) United States $22.986B 34.00
STERIS (STE) Ireland $22.207B 25.91
SONOVA HOLDING (SONVY) Switzerland $21.889B 0.00
Hologic (HOLX) United States $19.123B 20.79
Fresenius Medical Care AG KGaA (FMS) Germany $11.596B 13.00
Sysmex ADR (SSMXY) Japan $11.505B 0.00
Globus Medical (GMED) United States $10.139B 28.36
Teleflex (TFX) United States $9.809B 15.65
Penumbra (PEN) United States $8.954B 87.71
Masimo (MASI) United States $7.672B 41.09
Glaukos (GKOS) United States $7.241B 0.00
PROCEPT BioRobotics (PRCT) United States $4.816B 0.00
Integer Holdings (ITGR) United States $4.241B 24.04
Inari Medical (NARI) United States $2.853B 0.00
LivaNova (LIVN) United Kingdom $2.776B 16.03
TransMedics (TMDX) United States $2.765B 87.66
Veracyte (VCYT) United States $2.635B 163.38
Nihon Kohden (NHNKY) Japan $2.558B 15.91
Elekta AB (EKTAY) Sweden $2.267B 18.47
Tandem Diabetes Care (TNDM) United States $2.089B 0.00
RxSight (RXST) United States $1.890B 0.00
Integra LifeSciences Holdings (IART) United States $1.496B 6.81
Alphatec Holdings (ATEC) United States $1.150B 0.00
Artivion (AORT) United States $1.121B 102.89
OPKO Health (OPK) United States $1.053B 0.00
Pulse Biosciences (PLSE) United States $0.896B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.860B 14.62
Pacific Biosciences Of California (PACB) United States $0.665B 0.00
OrthoPediatrics (KIDS) United States $0.663B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.647B 0.00
Mesa Laboratories (MLAB) United States $0.638B 16.12
IRadimed (IRMD) United States $0.612B 33.08
AxoGen (AXGN) United States $0.611B 0.00
SiBone (SIBN) United States $0.562B 0.00
Paragon 28 (FNA) United States $0.470B 0.00
ClearPoint Neuro (CLPT) United States $0.356B 0.00
Tactile Systems Technology (TCMD) United States $0.349B 10.65
Treace Medical Concepts (TMCI) United States $0.297B 0.00
CVRx (CVRX) United States $0.292B 0.00
Delcath Systems (DCTH) United States $0.292B 0.00
AngioDynamics (ANGO) United States $0.271B 0.00
Sight Sciences (SGHT) United States $0.262B 0.00
Semler Scientific (SMLR) United States $0.215B 15.04
Nevro (NVRO) United States $0.206B 0.00
Inogen (INGN) United States $0.206B 0.00
NeuroPace (NPCE) United States $0.184B 0.00
Atossa Genetics (ATOS) United States $0.179B 0.00
Accuray (ARAY) United States $0.175B 0.00
Alpha Tau Medical (DRTS) Israel $0.160B 0.00
KORU Medical Systems (KRMD) United States $0.124B 0.00
Spectral Diagnostics (EDTXF) Canada $0.123B 0.00
908 Devices (MASS) United States $0.120B 0.00
Sensus Healthcare (SRTS) United States $0.108B 16.02
EDAP TMS S.A (EDAP) France $0.106B 0.00
WORK Medical Technology Group (WOK) China $0.088B 0.00
Monogram Orthopaedics (MGRM) United States $0.080B 0.00
Hyperfine (HYPR) United States $0.071B 0.00
Covalon Technologies (CVALF) Canada $0.067B 0.00
LENSAR (LNSR) United States $0.062B 0.00
InspireMD (NSPR) Israel $0.062B 0.00
Envoy Medical (COCH) United States $0.050B 0.00
Lucid Diagnostics (LUCD) United States $0.050B 0.00
Vicarious Surgical (RBOT) United States $0.048B 0.00
Rapid Micro Biosystems (RPID) United States $0.047B 0.00
Accelerate Diagnostics (AXDX) United States $0.046B 0.00
EnVVeno Medical (NVNO) United States $0.045B 0.00
Adagio Medical Holdings (ADGM) United States $0.036B 0.00
Neuronetics (STIM) United States $0.031B 0.00
DarioHealth (DRIO) United States $0.030B 0.00
Spectral AI (MDAI) United States $0.027B 0.00
Precision Optics (POCI) United States $0.026B 0.00
Ekso Bionics Holdings (EKSO) United States $0.020B 0.00
Biosig Technologies (BSGM) United States $0.018B 0.00
NexGel (NXGL) United States $0.018B 0.00
Baird Medical Investment Holdings (BDMD) $0.017B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.016B 0.00
Microbot Medical (MBOT) United States $0.016B 0.00
T2 Biosystems (TTOO) United States $0.015B 0.00
QT Imaging Holdings (QTI) United States $0.015B 0.00
Aspira Women's Health (AWH) United States $0.014B 0.00
Pixie Dust Technologies (PXDT) Japan $0.013B 0.00
Autonomix Medical (AMIX) United States $0.013B 0.00
PAVmed (PAVM) United States $0.011B 0.00
Check-Cap (CHEK) Israel $0.007B 0.00
ENDRA Life Sciences (NDRA) United States $0.005B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Nuwellis (NUWE) United States $0.003B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.002B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.001B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00